Clinical trial
Observational Study to Evaluate Safety of Cell-derived A/H1N1 Influenza HA Vaccine in Healthy Japanese Subjects
NCT01098786 is registered in ClinicalTrials.gov with Novartis Vaccines as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Observational Study to Evaluate Safety of Cell-derived A/H1N1 Influenza HA Vaccine in Healthy Japanese Subjects
- Lead sponsor
- Novartis Vaccines
- Phase
- Observational
- Overall status
- Completed
- Start date
- February 28, 2010
- Completion date
- November 30, 2010
- Enrollment
- 556 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
swine-origin influenza a h1n1 virus